Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Siebert

Showing results (151-160 of 359) with videos related to

Pageof 36
Sort By:
International Journal of Public Health|June 18, 2011
Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008Willi Oberaigner, Uwe Siebert, Wolfgang Horninger, et al.
German Medical Science : GMS E-Journal|August 14, 2009
Economic evaluation of newborn hearing screening: modelling costs and outcomesFranz Hessel, Eva Grill, Petra Schnell-Inderst, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapyGerald Hj Mickisch, Björn Schwander, Bernard Escudier, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3Uwe Siebert, Oguzhan Alagoz, Ahmed M Bayoumi, et al.
GMS Health Technology Assessment|February 4, 2011
Screening of the hearing of newborns - UpdatePetra Schnell-Inderst, Silke Kunze, Franz Hessel, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 5, 2004
Magnetic resonance angiography in the follow-up of distal lower-extremity bypass surgery: comparison with duplex ultrasound and digital subtraction angiographyOliver A Meissner, Frauke Verrel, Federico Tató, et al.
The Oncologist|November 29, 2015
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung CancerDavid D Stenehjem, Brandon K Bellows, Kraig M Yager, et al.
Value in Health Regional Issues|June 27, 2024
Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non-Small Cell Lung Cancer in JordanAbeer Al Rabayah, Rawan Al Froukh, Razan Sawalha, et al.
Pharmacoeconomics|June 3, 2009
Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelinesUwe Siebert, Gaby Sroczynski, Pamela Aidelsburger, et al.
European Heart Journal|August 29, 2025
Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT studyDavid Duncker, Eloi Marijon, Marco Metra, et al.
Pageof 36

Showing results (151-160 of 359) with videos related to

Sort By:
Pageof 36
International Journal of Public Health|June 18, 2011
Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008Willi Oberaigner, Uwe Siebert, Wolfgang Horninger, et al.
German Medical Science : GMS E-Journal|August 14, 2009
Economic evaluation of newborn hearing screening: modelling costs and outcomesFranz Hessel, Eva Grill, Petra Schnell-Inderst, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapyGerald Hj Mickisch, Björn Schwander, Bernard Escudier, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3Uwe Siebert, Oguzhan Alagoz, Ahmed M Bayoumi, et al.
GMS Health Technology Assessment|February 4, 2011
Screening of the hearing of newborns - UpdatePetra Schnell-Inderst, Silke Kunze, Franz Hessel, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 5, 2004
Magnetic resonance angiography in the follow-up of distal lower-extremity bypass surgery: comparison with duplex ultrasound and digital subtraction angiographyOliver A Meissner, Frauke Verrel, Federico Tató, et al.
The Oncologist|November 29, 2015
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung CancerDavid D Stenehjem, Brandon K Bellows, Kraig M Yager, et al.
Value in Health Regional Issues|June 27, 2024
Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non-Small Cell Lung Cancer in JordanAbeer Al Rabayah, Rawan Al Froukh, Razan Sawalha, et al.
Pharmacoeconomics|June 3, 2009
Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelinesUwe Siebert, Gaby Sroczynski, Pamela Aidelsburger, et al.
European Heart Journal|August 29, 2025
Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT studyDavid Duncker, Eloi Marijon, Marco Metra, et al.
Pageof 36